Wuhan Huakang Soars 8.87%, Hits Intraday High of CNY 57.36

Wuhan Huakang Century Medical Co., Ltd. has experienced a significant surge in its stock price, gaining 8.87% on March 6, 2026. The stock reached an intraday high of CNY 57.36, reflecting strong performance compared to the China Shanghai Composite, which only rose by 0.38% on the same day. Over the past year, Wuhan Huakang has delivered impressive returns of 171.15%, significantly outperforming the broader market. The company's performance metrics indicate a robust growth trajectory, with net sales increasing at an annual rate of 24.29% and operating profit rising by 13.72% over the last five years. Additionally, the stock has shown resilience in the short term, with a 2.56% increase over the past week and a 10.91% rise in the last month. Despite its high debt-to-equity ratio of 0.29, the company has managed to maintain a return on equity of 5.99%. With a market capitalization of CNY 1,096 million, Wuhan Huakang continues to position itself as a notable player in the pharmaceuticals and biotechnology sector.